You're reading a free article with opinions that may differ from The Motley Fool's Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More
Some of the factors that may have turned Buffett off to JNJ recently.
Our health-care roundtable gathers The Motley Fool's top health-care analysts to discuss the sector's biggest stories in a free flowing and highly opinionated format.
In this portion of the video, the guys speculate on what Johnson & Johnson (JNJ 1.19%) should be doing for shareholders, and why the company's lack of interest in share buybacks now might be a reason Warren Buffett's Berkshire Hathaway (BRK.A 1.53%) walked away.
Brenton Flynn and David Williamson have no positions in the stocks mentioned above. The Motley Fool owns shares of Johnson & Johnson. Motley Fool newsletter services recommend Johnson & Johnson. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
Stocks Mentioned
*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.
Related Articles
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.
